Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New antipsychotic drug in phase I at P&U

April 5, 1996

New antipsychotic drugs from HMR

April 5, 1996

Meiji claims improved antipsychotic agents

April 5, 1996

Pherin develops vomeropherins for anxiety

April 5, 1996

Lilly's tachykinin antagonists for chronic pain

April 5, 1996

Solvay acquires betahistine rights

March 15, 1996

Alpha2-adrenoceptor antagonists with neuroprotective effects

March 15, 1996

Astra antioxidants for hypoxia

March 15, 1996

Pierre Fabre reports antioxidants with neurologic activity

March 15, 1996

Antioxidants to treat Alzheimer's disease?

March 15, 1996

Popular Stories

FDA says changes in Dexcom G6, G7 sensors constitute misbranding
BioWorld MedTech
The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures...
Today's news in brief
BioWorld
BioWorld briefs for March 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 28, 2025
CMV history cited in DMD liver death on Sarepta’s Elevidys
BioWorld
Wall Street was weighing the gravity of the death from acute liver failure of a patient who was treated for Duchenne muscular dystrophy (DMD) with Sarepta...
UK government abolishes NHS England
BioWorld MedTech
In a move that surprised many across the health care sector, the U.K. government decided to scrap NHS England, the body which runs the national health service...